Renal proximal tubular cells – nephrotoxicity interaction

Renal proximal tubular cells (RPTCs) are the primary site of drug-induced nephrotoxicity due to their high metabolic activity and central role in the transport of xenobiotics. This interaction describes the process by which therapeutic agents or their metabolites are concentrated within these cells, often via specific uptake transporters like Organic Anion Transporters (OATs) or Organic Cation Transporters (OCTs), leading to cellular damage [1][2]. The resulting toxicity typically manifests as oxidative stress, mitochondrial impairment, and the activation of apoptotic or necrotic pathways, which can progress to acute kidney injury (AKI) [3]. Many potent drugs, including platinum-based chemotherapeutics and aminoglycoside antibiotics, are limited in clinical use by their specific toxic effects on the proximal tubule [4]. Monitoring this interaction is critical in drug development and clinical practice, utilizing biomarkers such as Kidney Injury Molecule-1 (KIM-1) and NGAL to detect early tubular damage before significant loss of glomerular filtration occurs [5]. This entry is classified as incorrect as a target because it represents a complex cell-drug interaction and toxicological endpoint rather than a single molecular therapeutic target like a receptor or enzyme.

Other names

Drug-induced kidney injuryProximal tubule toxicityDIKIRenal tubular necrosisNephrotoxicity

Drug accumulation via apical or basolateral transporters leading to oxidative stress, mitochondrial dysfunction, and apoptosis within the proximal tubule.